Ajanta Pharma Limited
Climate Impact & Sustainability Data (2020-04 to 2021-03, 2021-04 to 2022-03, 2022-23, 2023-24)
Reporting Period: 2020-04 to 2021-03
Environmental Metrics
ESG Focus Areas
- Ethics, Transparency and Accountability
- Sustainable Product Lifecycle
- Employee Wellbeing
- Stakeholder Engagement
- Human Rights
- Environmental Protection
- Inclusive Growth
- Customer Engagement
Environmental Achievements
- Reduced overall fresh solvent consumption in API unit by effective recovery of solvents.
- Treated wastewater used for maintaining green belt across the site.
- Recycling of used plastics, HDPE drums, shippers etc.
- Partially solid organic waste sent to cement industries for co-incineration.
- Installed solar plants in most plants, resulting in 32 Lac kwh solar energy consumption and reduced carbon emission.
- Installed ground mounted solar power plant at Pithampur facility, saving 50% energy charges and reducing carbon footprint.
Social Achievements
- CSR spending of ₹12.78 cr (1.89% of profit after tax) on healthcare, education, community welfare, and COVID-19 assistance.
- 90% of procurements sourced from domestic producers, with preference to local & MSME vendors.
- Training programs and workshops for local and small producers.
- Various CSR initiatives for the underprivileged sections of society and sports promotion.
Governance Achievements
- Code of Conduct for Directors and Senior Management, extending to the group including all its employees, Directors & subsidiaries.
- Whistleblower Policy in place.
- Annual BR performance assessment by internal audit team.
Climate Goals & Targets
Environmental Challenges
- No specific challenges explicitly mentioned in the report.
Mitigation Strategies
- Developing alternate reliable vendors to ensure business continuity.
- Implementing energy conservation projects across business units.
- Addressing potential environmental risks through Management System approach.
Supply Chain Management
Responsible Procurement
- Sourcing from approved vendors audited by quality assurance team.
- Developing alternate reliable vendors.
- Building capacity and sharing best practices amongst business partners.
- Preference given to local & MSME vendors.
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: National Voluntary Guidelines on social, environmental and economical responsibilities of business
Sustainable Products & Innovation
- Peroduo (anti-acne)
- Lidocam CT – Sugar free (Opioid & NSAID)
- Duranzo (Pain Management local anesthetic)
- Azusa T 8/40 (Antihypertensive)
- Cardiosel OD (Antihypertensive)
Reporting Period: 2021-04 to 2022-03
Environmental Metrics
Total Carbon Emissions:51244.37 tCO2e/year
Scope 1 Emissions:4611.22 tCO2e/year
Scope 2 Emissions:46633.15 tCO2e/year
Renewable Energy Share:8% of total energy use
Total Energy Consumption:288469.46 GJ/year
Water Consumption:282129 kl/year
Waste Generated:557.63 tons/year
Carbon Intensity:0.0017 kg CO2 per rupee of turnover
ESG Focus Areas
- Product Quality and Safety
- Occupational Health and Safety
- Regulatory Compliance
- Product Innovation
- Sustainable Supply Chain Management
- Human Rights
- Risk Management
- Renewable Energy
- Plastic Waste Management
- Community Upliftment
Environmental Achievements
- Recycling of 100% recyclable plastic waste.
- Reduced 40399 Tonnes of CO2 emissions through solar plants.
- Achieved Zero Liquid Discharge at all manufacturing plants (partially implemented).
Social Achievements
- Conducted vaccination camps for employees and in rural areas.
- Provided access to mental health therapists for employees.
- Conducted hobby development sessions for employees.
- CSR initiatives benefiting 200,000+ people in health, education, and other areas.
Governance Achievements
- Established stringent quality control and quality assurance processes.
- Implemented a robust grievance redressal mechanism.
- Established Internal Complaints Committee (ICC) and Business Integrity Committee to address complaints.
Climate Goals & Targets
Medium-term Goals:
- Enhance Renewable Energy consumption to 50% by 2026.
Environmental Challenges
- Maintaining product quality and safety.
- Ensuring occupational health and safety.
- Meeting regulatory compliance requirements.
- Sustainable supply chain management.
- Managing risks associated with the pharmaceutical business (regulatory, competition, supply chain, cyber security, etc.).
Mitigation Strategies
- Stringent quality control and quality assurance processes.
- Effective health and safety management system.
- Tracking and managing regulatory compliances.
- Abiding by UN Charter, Universal Declaration of Human Rights, and ILO conventions.
- Well-established risk management system including risk identification, analysis, mitigation strategies, and implementation.
Supply Chain Management
Supplier Audits: 100%
Responsible Procurement
- Data collection on supplier certifications, SOPs, sanitation, etc. before onboarding.
- 90% local sourcing.
Climate-Related Risks & Opportunities
Reporting Period: 2022-23
Environmental Metrics
Total Carbon Emissions:8557.87 tCO2e/year (Scope 1 & 2)
Scope 1 Emissions:4368.55 tCO2e/year
Scope 2 Emissions:51813.33 tCO2e/year
Renewable Energy Share:11%
Water Consumption:422760 m3/year
Waste Generated:2413.82 tons/year
ESG Focus Areas
- Environment
- Social
- Governance
Environmental Achievements
- Reduced coal usage by 2,493 tonnes
- Saved 238,553 trees from cutting
- Reduced CO2 emission by 3,364 tonnes
- Reduced water consumption by 12,315 kl
- Increased renewable energy share to 11% (short-term goal of 32% in next six months, 50% in two years)
Social Achievements
- Received "Best Managed Companies for 2022" award from Deloitte
- Received "Great Place to Work" recognition
- Conducted largest CPR training campaign (Asia Book of Records)
Governance Achievements
- Well-defined ESG policies implemented
- Robust Enterprise Risk Management (ERM) framework in place
- Robust system of internal controls
Climate Goals & Targets
Long-term Goals:
- Achieve 100% renewable energy by 2032
Medium-term Goals:
- Achieve 50% renewable energy by 2026
- Reduce waste by 20% by 2026
- Reduce water consumption by 30% by 2026
- Become water positive by 2030
Short-term Goals:
- Achieve 32% renewable energy in next six months
- Achieve 50% renewable energy in two years
Environmental Challenges
- High raw material and freight costs
- Price erosion in the US Generics business
- Lower demand from sponsors in the Africa Institutional business
- Logistics challenges in Africa
- Indian Rupee's appreciation against the Euro
Mitigation Strategies
- Increased capital allocation to Branded Generics business
- Accelerated product filing and enhanced ground presence
- Focus on select high-growth potential countries
- Enhancing field team productivity with digital tools
- Expecting normalization of freight costs
Supply Chain Management
Responsible Procurement
- ESG parameter-based supplier screening
- Sourcing >90% requirements from local communities
Climate-Related Risks & Opportunities
Awards & Recognition
- Best Managed Companies for 2022 (Deloitte)
- Great Place to Work
Reporting Period: 2023-24
Environmental Metrics
Total Carbon Emissions:46390.96 tCO2e/year (Scope 1 & 2)
Scope 1 Emissions:6390.22 tCO2e/year
Scope 2 Emissions:40007.74 tCO2e/year
Renewable Energy Share:30%+
Water Consumption:410951 m3/year
Waste Generated:2498.57 tons/year
ESG Focus Areas
- Clean & Green Energy Utilisation
- Sustainability
- Water Neutrality
- Employee Well-being
- Human Rights
- Responsible Sourcing
- Ethical Business Conduct
- Community Welfare
Environmental Achievements
- Commissioned a new 6.4 MW solar power plant, increasing renewable energy portfolio to 30%+ of total energy consumption. Reduced CO2 emissions by 4,200 tonnes annually.
- Maintaining water neutrality and following a zero-discharge policy at facilities.
- Reduced wastewater generation by 30% at Dahej plant.
- Recycled around 40 KLD of condensate, reducing boiler fuel consumption and CO2 emission.
- Implemented solvent waste recycling initiative.
Social Achievements
- Launched 42 new products.
- Added 300+ employees.
- Enhanced promotional efforts.
- Recognized as a 'Great Place to Work' for the second consecutive year.
- CSR initiatives in healthcare, education, rural development, and community welfare.
Governance Achievements
- Established robust Enterprise Risk Management (ERM) framework.
- Implemented a comprehensive Code of Conduct for Directors and Senior Management.
- Implemented a robust system of internal controls.
- Complied with all applicable Secretarial Standards.
Climate Goals & Targets
Long-term Goals:
- Net zero emissions by 2050 (implied)
Medium-term Goals:
- Achieve 100% renewable energy by 2032.
Short-term Goals:
- Increase renewable energy to over 50% in the next two years.
- Reduce water consumption by 10% by 2025.
- Reduce waste per unit of production by 10% annually and 30% by 2030.
- Reduce energy consumption by 10% by 2026 and 15% by 2028.
- Reduce Scope 1 and Scope 2 emissions by 10% by 2026 and 30% by 2030.
Environmental Challenges
- Volatility in API prices and international logistics costs.
- Tepid growth in the African market due to distributor inventory rationalisation.
- Uncertainty in the African Institutional business due to reliance on procurement agencies' funding.
Mitigation Strategies
- Partnered with vendors and industry experts to mitigate API price and logistics cost volatility, resulting in savings of ~₹100+ crore.
- Improved efficiencies across functions.
- Focused execution of strategies to grow Branded Generics business beyond normal industry growth.
Supply Chain Management
Supplier Audits: 10% upstream and 11% downstream partners (by value of business) assessed for ESG factors.
Responsible Procurement
- Third-Party Code of Conduct covering human rights, fair employment practices, environmental sustainability, and ethical business practices.
- Preferential procurement policy for MSMEs.
Climate-Related Risks & Opportunities
Opportunities
- Development of energy-efficient products and processes; investment in renewable energy.
Reporting Standards
Frameworks Used: GRI, BRSR
Certifications: ISO 14001, ISO 45001
Sustainable Products & Innovation
- Non-comedogenic dermatological formulations
- Preservative-free ophthalmic products
Awards & Recognition
- Apex India Safe Workplace Gold Award 2023
- Apex India Green Leaf Platinum Award for Sustainability 2023
- SKOCH ESG Award 2024 for Clean & Green Energy Utilisation
- Great Place To Work® Certification